Annals of the American Thoracic Society
Scope & Guideline
Connecting researchers and clinicians for a healthier tomorrow.
Introduction
Aims and Scopes
- Pulmonary Diseases and Disorders:
The journal covers a wide range of topics related to various pulmonary conditions, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung diseases, and pulmonary hypertension, with an emphasis on both clinical and translational research. - Critical Care Medicine:
Research in this area includes studies on managing critically ill patients, with a focus on respiratory failure, mechanical ventilation, and the impact of critical illness on long-term outcomes. - Sleep Medicine:
The journal publishes work on sleep-disordered breathing, including obstructive sleep apnea, its impact on overall health, and treatment strategies. - Public Health and Environmental Impacts:
Research addressing the intersections of respiratory health with public health issues, such as air pollution, smoking cessation, and health disparities, is a significant focus. - Innovative Therapeutics:
The journal highlights studies on novel therapeutic approaches, including biologics and pharmacological treatments for various pulmonary conditions. - Multidisciplinary Approaches:
Research that involves collaborative efforts across specialties, including insights from epidemiology, genetics, and health services research, is emphasized to address complex pulmonary issues.
Trending and Emerging
- Impact of COVID-19 on Respiratory Health:
A significant surge in studies related to the long-term effects of COVID-19 on pulmonary health, including post-COVID syndrome and its management, reflects the ongoing repercussions of the pandemic on respiratory care. - Telemedicine and Remote Patient Monitoring:
The rise of telehealth practices, particularly post-COVID-19, is leading to an increase in research on the effectiveness and implementation of telemedicine in managing chronic respiratory conditions. - Health Disparities and Equity:
There is an increasing focus on health equity, particularly regarding race, socioeconomic status, and access to care, as well as the impact of social determinants of health on pulmonary outcomes. - Artificial Intelligence and Machine Learning Applications:
Emerging research is increasingly utilizing AI and machine learning to improve diagnostics, treatment strategies, and predictive modeling in respiratory diseases. - Environmental Health and Respiratory Disease:
A growing body of literature examines the effects of environmental factors, including air pollution and climate change, on respiratory health, emphasizing the need for interdisciplinary approaches. - Personalized Medicine in Pulmonary Care:
There is a notable trend towards personalized approaches in treatment, particularly in asthma and COPD management, involving genetic, phenotypic, and biomarker-driven strategies.
Declining or Waning
- Traditional Epidemiological Studies:
There has been a noticeable decrease in the publication of traditional epidemiological studies that do not incorporate newer methodologies or technologies, such as big data analytics or machine learning, which are increasingly in demand. - Basic Science Research:
Although foundational research remains important, there appears to be a waning interest in purely laboratory-based studies without direct clinical implications, as the focus shifts towards translational research with immediate applications in patient care. - Single-Disease Focus:
Research that concentrates on single diseases in isolation is becoming less common, with a broader trend towards studies that consider comorbid conditions and the interconnectedness of various pulmonary disorders. - Outdated Treatment Protocols:
As new guidelines and treatment modalities emerge, older treatment protocols and their efficacy are being phased out, leading to fewer studies focused on traditional management strategies. - Non-comprehensive Health Disparities Studies:
Research focusing solely on health disparities without integrating social determinants of health or systemic factors has seen a decline, as the field moves towards more holistic approaches.
Similar Journals
Chronic Respiratory Disease
Innovating solutions for chronic respiratory challenges.Chronic Respiratory Disease is a leading peer-reviewed journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by SAGE Publications Ltd since its inception in 2004, this open-access journal has been at the forefront of disseminating high-quality research aimed at addressing chronic respiratory conditions. With an impressive impact factor and classified as Q1 in the 2023 category of Pulmonary and Respiratory Medicine, it ranks an admirable #45 out of 155 in Scopus, placing it in the 71st percentile of its field. This journal features a diverse range of studies, reviews, and clinical insights that cater to researchers, healthcare professionals, and students alike, encouraging the exchange of innovative ideas and practices in respiratory disease management. Operating out of London, UK, Chronic Respiratory Disease exemplifies a commitment to openness, having transitioned to open access since 2017, thereby ensuring that pivotal research is readily accessible to a global audience engaged in the improvement of respiratory health.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Enhancing clinical outcomes through impactful research.American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.
LUNG
Elevating respiratory medicine through rigorous research.LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.
THORAX
Championing excellence in respiratory research.THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Innovating for a Healthier Respiratory FutureThe AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, published by the esteemed American Thoracic Society, is a premier platform dedicated to advancing knowledge in the fields of pulmonary and respiratory medicine, cell biology, and clinical biochemistry. With an impressive impact factor and recognition as a Q1 journal in multiple categories for 2023, it ranks among the top tier of scholarly publications, evidencing its influence and contribution to the scientific community. Since its inception in 1989, the journal has provided a critical forum for researchers and professionals to disseminate innovative findings and pivotal reviews, driving forward the frontiers of respiratory biology. While the journal currently operates under traditional access mechanisms, it seeks to bridge gaps in research by presenting high-quality articles that address vital health challenges. As a key resource for both established researchers and emerging scholars in molecular biology and respiratory science, this journal plays a pivotal role in shaping the future of respiratory health advancements.
Turkish Thoracic Journal
Elevating respiratory medicine with open-access discoveries.Turkish Thoracic Journal, published by AVES, is a prominent open-access platform dedicated to advancing the field of pulmonary and respiratory medicine. Since its establishment, the journal has aimed to disseminate significant research findings, clinical studies, and reviews that contribute to an improved understanding of respiratory health challenges, with a particular focus on the Turkish context and regional issues. With an E-ISSN of 2149-2530 and transitioning to open access in 2022, the journal enhances visibility and accessibility, inviting a global audience of researchers, clinicians, and students to engage with the latest scientific work. The Turkish Thoracic Journal has been indexed in major databases, although it faced a coverage discontinuation in Scopus between 2016 and 2022. Currently positioned within the 23rd percentile among its peers in the field, it invites submissions that explore innovative approaches to thoracic health, enriching the discourse in a vital area of medicine.
Lung India
Empowering knowledge for better lung care.Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.
Egyptian Journal of Bronchology
Fostering collaboration in the fight against bronchial diseases.Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.
BMC Pulmonary Medicine
Connecting researchers and practitioners for impactful insights.BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.
Pulmonology
Pioneering insights for a healthier tomorrow in pulmonology.Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.